Reduction of tricuspid regurgitation by transcatheter tricuspid edge-to-edge valve repair improved liver function and did not harm kidney function, according to data presented at EuroPCR. Nicole Karam ...
In patients with postoperative right ventricular outflow tract conduit dysfunction and significant baseline tricuspid regurgitation, transcatheter pulmonary valve replacement appears to yield ...
Tricuspid regurgitation — a leak in the heart’s tricuspid valve that allows blood to flow back from the right ventricle to the right atrium — is relatively rare after a mitral valve repair procedure, ...
Patients with tricuspid regurgitation, a common and debilitating form of valvular heart disease, who received a novel investigational device intended to repair the defective valve experienced ...
WASHINGTON -- A roundup of new devices designed to treat tricuspid regurgitation revived a long-standing kerfuffle between surgeons and interventionists on what roles they have when encountering a ...
PARIS, France—Percutaneous edge-to-edge repair with a clip device appears to offer some hope for patients with tricuspid regurgitation, according to new results from the TRILUMINATE study. At 30 days, ...
While minimally invasive repair devices have shown progress in stemming leaks of the heart’s notoriously tricky tricuspid valve, Edwards Lifesciences aims to show that replacing the valve entirely ...
Share on Facebook. Opens in a new tab or window Share on Bluesky. Opens in a new tab or window Share on X. Opens in a new tab or window Share on LinkedIn. Opens in a new tab or window PHOENIX -- ...
In the shadow of the wildly successful transcatheter aortic valve replacement (TAVR) market, the tricuspid valve was once viewed as the forgotten valve. That is quickly changing, however, as ...
DUBLIN--(BUSINESS WIRE)--CroíValve, a pioneering medical device company focused on the development of a novel transcatheter device for the treatment of severe+ tricuspid regurgitation (TR), announced ...
The US Centers for Medicare & Medicaid Services (CMS) has finalized its national coverage determination (NCD) for transcatheter tricuspid valve replacement (TTVR) when used to treat patients with ...